Click here to go to the previous page
Drug Rediscovery as an Innovative Tool to Meet Unmet Medical Needs
Program Code:
252
Date:
Tuesday, June 26, 2012
Time:
1:30 PM to 3:00 PM
EST
CHAIR
:
John Lisman,
Lisman Legal Life Sciences B.V., Netherlands
John Lisman is a pharmacist and lawyer by education. After a carreer in the Ministry of Health and the EU competent authorities he qualified as attorney at NautaDutilh N.V. Since May 2010 he practices law and regulatory consultancy from Lisman Legal Life sciences B.V.
|
PRESENTER
(S):
John Lisman,
Lisman Legal Life Sciences B.V., Netherlands
John Lisman is a pharmacist and lawyer by education. After a carreer in the Ministry of Health and the EU competent authorities he qualified as attorney at NautaDutilh N.V. Since May 2010 he practices law and regulatory consultancy from Lisman Legal Life sciences B.V.
|
Chris Mulder, VU University Medical Center, Netherlands
Steven Lehrer, Fermata Pharma, Inc, United States
Description
Drug Rediscovery is the science dealing with the use of old active substances to develop new treatments. This session focuses on the benefits and challenges of drug rediscovery.
Learning Objectives:
Discuss the opportunities and challenges of drug rediscovery
Discuss how to add a new use of older drugs to the innovation tool box: Identify current examples of drug rediscovery.